CytoSite BioPharma Inc.
Biotechnology company · Sudbury, Massachusetts, United States
CytoSite BioPharma Inc. is a biotechnology company headquartered in Sudbury, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2020.
CytoSite BioPharma at a glance
What does CytoSite BioPharma do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.8 million in total (2018 to 2019). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $3 million sold (2020).
Frequently asked questions about CytoSite BioPharma
Where is CytoSite BioPharma headquartered?
CytoSite BioPharma Inc. is headquartered in Sudbury, Massachusetts, United States.
What does CytoSite BioPharma do?
CytoSite BioPharma Inc. is a biotechnology company.
When was CytoSite BioPharma founded?
The earliest incorporation on record for CytoSite BioPharma Inc. is in 2016, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.